Evaluation of the Neonatal Autonomic Stress During Intubations Under Propofol in a Population of Premature Infants Under 33 w'GA (PROPOSURF)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03721640|
Recruitment Status : Recruiting
First Posted : October 26, 2018
Last Update Posted : January 19, 2021
Hyaline membrane disease is one of the leading causes of morbidity and mortality in premature newborns in industrialized countries. For 30 years, the management of the hyaline membranes disease has been transformed by intratracheal administration of exogenous surfactant (Curosurf®) at birth or in the following hours. In order to limit the harmful effects in terms of barotrauma of mechanical ventilation, several methods have been developed over the last decades, aiming at limiting the mechanical ventilation to the profile of non-invasive ventilation: Thus the administration of surfactant has become faster (although invasive) and if possible followed by immediate extubation following the INSURE (INtubation / SURfactant / Extubation) or LISA (Less-Invasive Surfactant Administration) procedure.
Given the fragility of the children concerned and their low weight, this invasive gesture has long been carried out without premedication. However, taking into account the pain induced and potential hemodynamic consequences of the gesture, neonatal societies now recommend the use of anesthetic before intubation, with a short duration sedative.
Propofol is a general anesthetic that combines these conditions and is widely used in pediatric anesthesia.
In that way, since 2016, the invetigators have modified the sedation protocol for intubation in our department and have recommended Propofol as first-line treatment for term and preterm newborn. A lot of study showed its hemodynamic safety in preterms. However, the investigators lack data on the autonomic stress really observed during intubation in this population. The investigators therefore propose to evaluate these physiological data in a non-randomized prospective observational study in premature infants under 33 weeks of gestational amenorrhea (GA), during a sedation protocol for intubation and surfactant administration according the INSURE or LISA technique, with standardized doses of propofol : 1mg/kg for preterm infants with a birthweight less than 1.5kg and 1.5mg/kg for higher birthweight.
|Condition or disease||Intervention/treatment|
|Hyaline Membrane Disease Preterm Infant||Other: electrocardiogram|
|Study Type :||Observational|
|Estimated Enrollment :||30 participants|
|Official Title:||Evaluation of the Neonatal Autonomic Stress During Intubations Under Propofol in a Population of Premature Infants Under 33 w'GA|
|Actual Study Start Date :||February 25, 2019|
|Estimated Primary Completion Date :||October 2021|
|Estimated Study Completion Date :||October 2021|
Preterm neonates (< 33 weeks GA)
Preterm neonates requiring in the first week of life, an elective tracheal intubation for surfactant administration by INSURE or LISA methods.
Autonomic and hemodynamic evaluation with different indices (LF, heart rate, Systolic, diastolic and mean arterial blood pressure, SaO2) during a sedation protocol for intubation and surfactant administration according the INSURE or LISA technique.
- Real-time LF values (low frequency) [ Time Frame: during surfactant administration procedure ]
- represent the well-being sympathetic activity of the autonomic nervous system
- measured with electrocardiogram
- heart rate [ Time Frame: during surfactant administration procedure ]- measured with electrocardiogram
- systolic arterial blood pressure [ Time Frame: during surfactant administration procedure ]- measured with a blood pressure cuff
- diastolic arterial blood pressure [ Time Frame: during surfactant administration procedure ]- measured with a blood pressure cuff
- Oxygen saturation [ Time Frame: during surfactant administration procedure ]- measured by pulse oximetry
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03721640
|Contact: Hugues PATURAL||04 77 82 85 42 ext +email@example.com|
|CHU de Saint Etienne||Recruiting|
|Saint-Étienne, France, 42055|
|Contact: Hugues PATURAL, MD PhD 04 77 82 85 42 ext +33 firstname.lastname@example.org|
|Principal Investigator: Hugues PATURAL, MD PhD|
|Principal Investigator:||Hugues PATURAL||CHU de Saint Etienne|